×
Entrez Id:
5241
Gene Symbol:
PGR
PGR
0.310
Biomarker
disease
BEFREE
All secretory meningiomas were positive for EMA and PR and negative for S100, and this pattern exhibited a rostrocaudal gradient.
30503291
2019
×
Entrez Id:
4771
Gene Symbol:
NF2
NF2
0.310
Biomarker
disease
CTD_human
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
23334667
2013
×
Entrez Id:
5241
Gene Symbol:
PGR
PGR
0.310
Biomarker
disease
CTD_human
Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy.
19731987
2010
×
Entrez Id:
5241
Gene Symbol:
PGR
PGR
0.310
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
4771
Gene Symbol:
NF2
NF2
0.310
Biomarker
disease
BEFREE
Our results may indicate a molecular, besides morphologic, similarity between secretory and meningothelial meningiomas: the almost constant merlin immunohistochemical expression in our series gives evidence for a possible NF2 gene-independent pathogenesis in secretory meningiomas .
17721284
2007
×
Entrez Id:
5241
Gene Symbol:
PGR
PGR
0.310
Biomarker
disease
CTD_human
Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
8008172
1994
×
Entrez Id:
8314
Gene Symbol:
BAP1
BAP1
0.300
Biomarker
disease
CTD_human
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
25231345
2015
×
Entrez Id:
6608
Gene Symbol:
SMO
SMO
0.300
Biomarker
disease
CTD_human
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
23334667
2013
×
Entrez Id:
207
Gene Symbol:
AKT1
AKT1
0.300
Biomarker
disease
CTD_human
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
23334667
2013
×
Entrez Id:
8028
Gene Symbol:
MLLT10
MLLT10
0.300
Biomarker
disease
CTD_human
Common variation at 10p12.31 near MLLT10 influences meningioma risk.
21804547
2011
×
Entrez Id:
3280
Gene Symbol:
HES1
HES1
0.300
Biomarker
disease
CTD_human
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
21127729
2010
×
Entrez Id:
1476
Gene Symbol:
CSTB
CSTB
0.300
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
1471
Gene Symbol:
CST3
CST3
0.300
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
1514
Gene Symbol:
CTSL
CTSL
0.300
Biomarker
disease
CTD_human
Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
19747051
2010
×
Entrez Id:
210
Gene Symbol:
ALAD
ALAD
0.300
Biomarker
disease
CTD_human
Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.
16140629
2005
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
0.300
Biomarker
disease
CTD_human
A novel germline mutation of PTEN associated with brain tumours of multiple lineages.
12085208
2002
×
Entrez Id:
9314
Gene Symbol:
KLF4
KLF4
0.030
Biomarker
disease
BEFREE
KLF4 , a transcription factor known for its role in stemness maintenance, was identified as one of the most frequently mutated genes in the benign secretory meningioma .
28651379
2017
×
Entrez Id:
9314
Gene Symbol:
KLF4
KLF4
0.030
GeneticVariation
disease
BEFREE
To our knowledge, these are the first two cases reported of the simultaneous occurrence of secretory meningiomas with mutation of KLF4 in collision with a glioblastoma and an anaplastic astrocytoma, respectively.
26227255
2016
×
Entrez Id:
9314
Gene Symbol:
KLF4
KLF4
0.030
GeneticVariation
disease
BEFREE
While KLF4 mutations were exclusively seen in secretory meningiomas , TRAF7 mutations were also observed in 7/89 (8 %) of non-secretory meningiomas .
23404370
2013
×
Entrez Id:
84231
Gene Symbol:
TRAF7
TRAF7
0.020
GeneticVariation
disease
BEFREE
KLF4- and TRAF7 -mutated tumors were predominantly secretory meningiomas .
31177425
2019
×
Entrez Id:
84231
Gene Symbol:
TRAF7
TRAF7
0.020
GeneticVariation
disease
BEFREE
While KLF4 mutations were exclusively seen in secretory meningiomas, TRAF7 mutations were also observed in 7/89 (8 %) of non-secretory meningiomas .
23404370
2013
SLC9A3R1
0.010
GeneticVariation
disease
BEFREE
In a meningioma series from 83 patients, NHERF1 revealed microlumens in 87.5% of the chordoid meningioma (<i>n</i> = 25) and meningioma with chordoid component (<i>n</i> = 7) cases, and in 100% of the secretory meningioma cases (<i>n</i> = 12).
29983887
2018
×
Entrez Id:
2335
Gene Symbol:
FN1
FN1
0.010
AlteredExpression
disease
BEFREE
Secretory meningiomas showed high expressions of fibronectin and galectin-3.
22995327
2013